FDA Approves Osteoporosis Drug Evista For Breast Cancer Treatment

[Omaha Steve]

Source: AHN News

Nidhi Sharma - AHN News Writer

Washington D.C. (AHN) - Evista, an osteoporosis drug, received a federal approval as a two-for-one treatment to prevent aggressive breast cancer in post-menopausal women on Friday.

The drug, produced by U.S.-based Eli Lilly, can lower the risk of invasive breast cancer in postmenopausal women with osteoporosis and those at high risk for invasive breast cancer, U.S. Food and Drug Administration (FDA) said Friday.

"Today's action provides an important new option for women at heightened risk of breast cancer," says Steven Galson, director of the FDA's Drug Evaluation and Research, in an FDA news release.

According to Lilly spokeswoman Sharon Corbitt, the company applied for the new use after conducting studies on about 37,000 postmenopausal women. Evista was introduced in 1998 for the prevention and treatment of osteoporosis.

Read more: http://www.allheadlinenews.com/articles/7008524241

[Trillo]

1. Another damn lie.

From the Prescribing Information:

Important Limitations: EVISTA is not indicated for the treatment of invasive
breast cancer, reduction of the risk of recurrence of breast cancer, or reduction
of risk of noninvasive breast cancer. (1.3)
http://pi.lilly.com/us/evista-pi.pdf

Don't the company lawyers and researchers have anything better to do than tell physicians, as well as any of the rest of us who try to be informed, lies?

"EVISTA is not indicated for the treatment of ..." is not the same as "EVISTA is not approved for the treatment of ..."